Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Boill Healthcare Holdings Limited ( (HK:1246) ) just unveiled an announcement.
Boill Healthcare Holdings Limited reported a sharp year-on-year increase in revenue to HK$51.7 million for the six months ended 30 September 2025, up from HK$32.5 million a year earlier, but gross profit nearly halved to HK$4.6 million as cost of sales rose significantly. The group’s loss for the period widened to HK$37.0 million from HK$28.5 million, driven by higher finance costs, increased administrative expenses, and substantial expected credit losses on financial guarantee contracts, while exchange losses deepened the total comprehensive loss to HK$56.5 million; basic and diluted loss per share expanded to HK2.61 cents, underscoring continued pressure on profitability and returns to shareholders.
More about Boill Healthcare Holdings Limited
Boill Healthcare Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare sector through its subsidiaries, generating revenue from healthcare-related services and/or products in its principal markets.
Technical Sentiment Signal: Sell
Current Market Cap: HK$28.52M
For detailed information about 1246 stock, go to TipRanks’ Stock Analysis page.